SRN-910

Serial Number 90503082
Registration 6755650
700

Registration Progress

Application Filed
Feb 1, 2021
Under Examination
Nov 23, 2021
Approved for Publication
Sep 28, 2021
Published for Opposition
Sep 28, 2021
Registered
Jun 7, 2022

Trademark Image

SRN-910

Basic Information

Serial Number
90503082
Registration Number
6755650
Filing Date
February 1, 2021
Registration Date
June 7, 2022
Published for Opposition
September 28, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 7, 2022
Registration
Registered
Classes
005

Rights Holder

Seragon Pharmaceuticals Inc.

03
Address
400 Spectrum Center Dr., Ste. 1600
Irvine, CA 92618

Ownership History

Seragon Pharmaceuticals Inc.

Original Applicant
03
Irvine, CA

Seragon Pharmaceuticals Inc.

Owner at Publication
03
Irvine, CA

Seragon Pharmaceuticals Inc.

Original Registrant
03
Irvine, CA

Legal Representation

Attorney
Chris P. Cheng

USPTO Deadlines

Next Deadline
863 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220607)
Due Date
June 07, 2028
Grace Period Ends
December 07, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Jul 9, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jul 9, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 9, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 9, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 7, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 7, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 4, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 3, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 20, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 5, 2022 IUAF S USE AMENDMENT FILED Loading...
Apr 19, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 5, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 23, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 28, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 28, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 8, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 20, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 4, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the prevention and treatment of cancer
First Use Anywhere: Apr 2, 2021
First Use in Commerce: Apr 2, 2021

Additional Information

Pseudo Mark
SRN NINE HUNDRED TEN; SRN NINE ONE ZERO

Classification

International Classes
005